Acadian Asset Management’s Bicycle Therapeutics BCYC Stock Holding History

Acadian Asset Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.32M	Hold	1,968,025	–	–	0.01%	656
2026 Q1	$9.11M	Buy	1,968,025 +296,767	+18%	+$1.7M	0.01%	555
2025 Q4	$11.8M	Buy	1,671,258 +356,702	+27%	+$2.63M	0.02%	448
2025 Q3	$10.2M	Buy	1,314,556 +616,055	+88%	+$4.65M	0.02%	481
2025 Q2	$4.84M	Buy	698,501 +572,439	+454%	+$4.56M	0.01%	595
2025 Q1	$1.06M	Buy	+126,062	New	+$1.49M	﹤0.01%	919
2022 Q3	–	Sell	-56,909	Closed	-$954K	–	1673
2022 Q2	$954K	Buy	56,909 +20,950	+58%	+$442K	﹤0.01%	833
2022 Q1	$1.58M	Sell	35,959 -142,580	-80%	-$6.66M	0.01%	719
2021 Q4	$10.9M	Buy	178,539 +157,365	+743%	+$8.68M	0.04%	299
2021 Q3	$878K	Buy	21,174 +12,221	+137%	+$427K	﹤0.01%	888
2021 Q2	$272K	Sell	8,953 -29,507	-77%	-$892K	﹤0.01%	1346
2021 Q1	$1.15M	Buy	38,460 +27,029	+236%	+$697K	﹤0.01%	904
2020 Q4	$205K	Buy	+11,431	New	+$221K	﹤0.01%	1544

Other funds holding BCYC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSK plc London $602M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FPC

Flax Pond Capital Falmouth, Massachusetts $127M AUM

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

Acadian Asset Management's BCYC Position: Q2 2026 in Review

Acadian Asset Management held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 1,968,025 shares worth $8.32M. The position accounts for 0.01% of the portfolio, ranked #656.

Acadian Asset Management first reported a position in BCYC in Q4 2020 and has held it in 13 quarters since. The position peaked at $11.8M in Q4 2025. 56 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

Acadian Asset Management held 1,968,025 shares of Bicycle Therapeutics worth $8.32M as of Q2 2026.
Acadian Asset Management left its Bicycle Therapeutics share count unchanged in Q2 2026.
Bicycle Therapeutics made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #656 holding.
Acadian Asset Management first reported a position in Bicycle Therapeutics in Q4 2020 and has held it in 13 quarters since.
Acadian Asset Management's Bicycle Therapeutics position peaked at $11.8M in Q4 2025.
56 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.